查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1307440

藥物檢測市場：按藥物檢測產品、樣本類型和最終用戶分類 - 全球預測 2023-2030

Drug Testing Market by Drug Testing Product, Sample Type, End-User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年全球藥物檢測市場將大幅成長222.5億美元，複合年成長率為12.16%，預計到2030年將達到驚人的497.6億美元。

FPNV定位矩陣

FPNV定位矩陣對於評估全球藥物檢測市場至關重要。通過檢查業務戰略和產品滿意度的關鍵指標，我們對供應商進行全面評估，使您能夠根據您的具體需求做出明智的資訊。這種高級分析將供應商分為四個像限，並取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市場佔有率分析

市場佔有率分析可以深入了解供應商在特定市場領域的當前地位。比較供應商對總收入、基本客群和其他關鍵指標的貢獻，可以幫助公司更好地了解他們在爭奪市場佔有率時的表現以及面臨的情況。該分析還揭示了特定行業的競爭程度、積累和合併的優勢以及研究基準年的合併特徵。

本報告提供了以下幾點見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開發：提供有關利潤豐厚的新興市場的詳細資訊，並分析其在成熟市場的滲透率。

3. 市場多元化：提供有關新產品發布、未開發地區、最新發展和投資的詳細資訊。

4.市場趨勢：全面了解COVID-19、俄羅斯-烏克蘭衝突和高通貨膨脹的累積影響。

5、競爭評估與資訊：對主要企業的市場佔有率、戰略、產品、認證、法規狀況、專利狀況、製造能力等進行綜合評價。

6. 產品開發和創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告回答了以下問題：

1. 全球藥物檢測市場規模及預測是多少？

2.在預測期內，COVID-19對全球藥物檢測市場的抑制要素和影響是什麼？

3. 預測期內全球藥物檢測市場需要投資哪些產品/細分市場/應用/領域？

4、全球藥檢市場的競爭策略是什麼？

5. 全球藥物檢測市場的技術趨勢和法律規範是什麼？

6.全球藥檢市場主要廠商的市場佔有率是多少？

7. 哪些型態和戰略舉措被認為適合進入全球藥檢市場？

目錄

第1章 前言

第2章 調查方法

第3章 執行摘要

第4章 市場概況

第5章 市場洞察

  • 市場動態
    • 促進因素
      • 藥物和酒精消費量增加
      • 政府對藥物和酒精測試的嚴格法規
      • 法規核准以及產品和服務開發的快速增加
    • 抑制因素
      • 一些國家限製藥物測試，因為它侵犯了隱私權
    • 機會
      • 開發先進的藥物測試解決方案
      • 智慧指紋藥品檢測系統
    • 任務
      • 解釋篩選測試中的技術和社會問題
  • 市場趨勢
  • COVID-19 的累積影響
  • 俄羅斯-烏克蘭衝突的累積影響
  • 高通貨膨脹的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範
  • 客戶客製化

第6章 藥檢市場（按藥檢產品分類）

  • 檢測試劑盒
  • 消耗品
  • 藥物篩選服務
  • 產品
    • 分析設備
      • 偵測
      • 色譜設備
      • 免疫檢測
    • 校準器和控制裝置
    • 快速檢查裝置
      • 口腔液檢查裝置
      • 尿液檢查裝置
    • 樣品採集管

第7章 藥品檢驗市場（按樣本類型）

  • 呼吸樣本
  • 頭髮樣本
  • 口腔液樣本
  • 尿樣

第8章 藥物測試市場：按最終用戶分類

  • 刑事司法系統和執法
  • 藥物檢測實驗室
  • 戒毒治療中心
  • 醫院
  • 個人用戶
  • 疼痛管理中心
  • 大學
  • 職場

第9章 美洲藥檢市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章 亞太藥檢市場

  • 澳大利亞
  • 中國
  • 印度
  • 印度尼西亞
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東及非洲藥品檢測市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭形勢

  • FPNV定位矩陣
  • 市場佔有率分析：主要企業
  • 競爭情景分析：主要企業

第13章上市公司名單

第14章附錄

  • 討論指南
  • 關於許可和定價
Product Code: MRR-B973EDD5EB1F

The Global Drug Testing Market is forecasted to grow significantly, with a projected USD 22.25 billion in 2023 at a CAGR of 12.16% and expected to reach a staggering USD 49.76 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Drug Testing Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Drug Testing Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Drug Testing Product, market is studied across Assay Kits, Consumables, Drug Screening Services, and Products. The Products is further studied across Analytical Instruments, Calibrators & Controls, Rapid Testing Devices, and Sample Collection Tubes. The Analytical Instruments is further studied across Breathalyzers, Chromatography Instruments, and Immunoassay Analyzers. The Rapid Testing Devices is further studied across Oral Fluid Testing Devices and Urine Testing Devices. The Products is projected to witness significant market share during forecast period.

Based on Sample Type, market is studied across Breath Samples, Hair Samples, Oral Fluid Samples, and Urine Samples. The Breath Samples is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Criminal Justice Systems & Law Enforcement Agencies, Drug Testing Laboratories, Drug Treatment Centers, Hospitals, Individual Users, Pain Management Centers, Universities, and Workplace. The Criminal Justice Systems & Law Enforcement Agencies is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Drug Testing Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Drug Testing Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Drug Testing Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Drug Testing Market?

4. What is the competitive strategic window for opportunities in the Global Drug Testing Market?

5. What are the technology trends and regulatory frameworks in the Global Drug Testing Market?

6. What is the market share of the leading vendors in the Global Drug Testing Market?

7. What modes and strategic moves are considered suitable for entering the Global Drug Testing Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Drug Testing Market, by Drug Testing Product, 2022 vs 2030
  • 4.3. Drug Testing Market, by Sample Type, 2022 vs 2030
  • 4.4. Drug Testing Market, by End-User, 2022 vs 2030
  • 4.5. Drug Testing Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing drug & alcohol consumption
      • 5.1.1.2. Stringent government regulations for drug & alcohol testing
      • 5.1.1.3. Surge in regulatory approvals and product & service development
    • 5.1.2. Restraints
      • 5.1.2.1. Restriction on the drug testing as it is violation of privacy rights in some countries
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of advanced drug testing solutions
      • 5.1.3.2. Intelligent fingerprint drug testing system
    • 5.1.4. Challenges
      • 5.1.4.1. Technical problem in interpreting screening tests and social issue
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Drug Testing Market, by Drug Testing Product

  • 6.1. Introduction
  • 6.2. Assay Kits
  • 6.3. Consumables
  • 6.4. Drug Screening Services
  • 6.5. Products
    • 6.5.1. Analytical Instruments
      • 6.5.1.1. Breathalyzers
      • 6.5.1.2. Chromatography Instruments
      • 6.5.1.3. Immunoassay Analyzers
    • 6.5.2. Calibrators & Controls
    • 6.5.3. Rapid Testing Devices
      • 6.5.3.1. Oral Fluid Testing Devices
      • 6.5.3.2. Urine Testing Devices
    • 6.5.4. Sample Collection Tubes

7. Drug Testing Market, by Sample Type

  • 7.1. Introduction
  • 7.2. Breath Samples
  • 7.3. Hair Samples
  • 7.4. Oral Fluid Samples
  • 7.5. Urine Samples

8. Drug Testing Market, by End-User

  • 8.1. Introduction
  • 8.2. Criminal Justice Systems & Law Enforcement Agencies
  • 8.3. Drug Testing Laboratories
  • 8.4. Drug Treatment Centers
  • 8.5. Hospitals
  • 8.6. Individual Users
  • 8.7. Pain Management Centers
  • 8.8. Universities
  • 8.9. Workplace

9. Americas Drug Testing Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Drug Testing Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Drug Testing Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. DRUG TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. DRUG TESTING MARKET SIZE, 2022 VS 2030
  • FIGURE 3. DRUG TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2022 VS 2030 (%)
  • FIGURE 5. DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2022 VS 2030 (%)
  • FIGURE 6. DRUG TESTING MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
  • FIGURE 7. DRUG TESTING MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 8. DRUG TESTING MARKET DYNAMICS
  • FIGURE 9. DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. DRUG TESTING MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS DRUG TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES DRUG TESTING MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC DRUG TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. DRUG TESTING MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 17. DRUG TESTING MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. DRUG TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. DRUG TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 5. DRUG TESTING MARKET SIZE, BY ASSAY KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. DRUG TESTING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. DRUG TESTING MARKET SIZE, BY DRUG SCREENING SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 9. DRUG TESTING MARKET SIZE, BY PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 11. DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. DRUG TESTING MARKET SIZE, BY BREATHALYZERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. DRUG TESTING MARKET SIZE, BY CHROMATOGRAPHY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. DRUG TESTING MARKET SIZE, BY IMMUNOASSAY ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. DRUG TESTING MARKET SIZE, BY CALIBRATORS & CONTROLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 17. DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. DRUG TESTING MARKET SIZE, BY ORAL FLUID TESTING DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. DRUG TESTING MARKET SIZE, BY URINE TESTING DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. DRUG TESTING MARKET SIZE, BY SAMPLE COLLECTION TUBES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. DRUG TESTING MARKET SIZE, BY BREATH SAMPLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. DRUG TESTING MARKET SIZE, BY HAIR SAMPLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. DRUG TESTING MARKET SIZE, BY ORAL FLUID SAMPLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. DRUG TESTING MARKET SIZE, BY URINE SAMPLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. DRUG TESTING MARKET SIZE, BY CRIMINAL JUSTICE SYSTEMS & LAW ENFORCEMENT AGENCIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. DRUG TESTING MARKET SIZE, BY DRUG TESTING LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. DRUG TESTING MARKET SIZE, BY DRUG TREATMENT CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. DRUG TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. DRUG TESTING MARKET SIZE, BY INDIVIDUAL USERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. DRUG TESTING MARKET SIZE, BY PAIN MANAGEMENT CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. DRUG TESTING MARKET SIZE, BY UNIVERSITIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. DRUG TESTING MARKET SIZE, BY WORKPLACE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS DRUG TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. CANADA DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. MEXICO DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. MEXICO DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 62. MEXICO DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 63. MEXICO DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 64. MEXICO DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. MEXICO DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES DRUG TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 67. UNITED STATES DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 69. UNITED STATES DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 70. UNITED STATES DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. UNITED STATES DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC DRUG TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. AUSTRALIA DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. AUSTRALIA DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 82. AUSTRALIA DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 83. AUSTRALIA DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 84. AUSTRALIA DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. AUSTRALIA DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. CHINA DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. CHINA DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 88. CHINA DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 89. CHINA DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 90. CHINA DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. CHINA DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. INDIA DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. INDIA DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 94. INDIA DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 95. INDIA DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 96. INDIA DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. INDIA DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. INDONESIA DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. INDONESIA DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 100. INDONESIA DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 101. INDONESIA DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 102. INDONESIA DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. INDONESIA DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. JAPAN DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. JAPAN DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 106. JAPAN DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 107. JAPAN DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 108. JAPAN DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. JAPAN DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. MALAYSIA DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. MALAYSIA DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 112. MALAYSIA DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 113. MALAYSIA DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 114. MALAYSIA DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. MALAYSIA DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. PHILIPPINES DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. PHILIPPINES DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 118. PHILIPPINES DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 119. PHILIPPINES DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 120. PHILIPPINES DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. PHILIPPINES DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. SINGAPORE DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. SINGAPORE DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 124. SINGAPORE DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 125. SINGAPORE DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 126. SINGAPORE DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SINGAPORE DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH KOREA DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH KOREA DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH KOREA DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH KOREA DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 132. SOUTH KOREA DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. SOUTH KOREA DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. TAIWAN DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. TAIWAN DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 136. TAIWAN DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 137. TAIWAN DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 138. TAIWAN DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. TAIWAN DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. THAILAND DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. THAILAND DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 142. THAILAND DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 143. THAILAND DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 144. THAILAND DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. THAILAND DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. VIETNAM DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 147. VIETNAM DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 148. VIETNAM DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 149. VIETNAM DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 150. VIETNAM DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. VIETNAM DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 159. DENMARK DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 160. DENMARK DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 161. DENMARK DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 162. DENMARK DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 163. DENMARK DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. DENMARK DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 165. EGYPT DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 166. EGYPT DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 167. EGYPT DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 168. EGYPT DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 169. EGYPT DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. EGYPT DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 171. FINLAND DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 172. FINLAND DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 173. FINLAND DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 174. FINLAND DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 175. FINLAND DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. FINLAND DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 177. FRANCE DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 178. FRANCE DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 179. FRANCE DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 180. FRANCE DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 181. FRANCE DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. FRANCE DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 183. GERMANY DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 184. GERMANY DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 185. GERMANY DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 186. GERMANY DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 187. GERMANY DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. GERMANY DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 189. ISRAEL DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 190. ISRAEL DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 191. ISRAEL DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 192. ISRAEL DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 193. ISRAEL DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 194. ISRAEL DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 195. ITALY DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 196. ITALY DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 197. ITALY DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 198. ITALY DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 199. ITALY DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. ITALY DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 202. NETHERLANDS DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 203. NETHERLANDS DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 204. NETHERLANDS DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 205. NETHERLANDS DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 206. NETHERLANDS DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 207. NIGERIA DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 208. NIGERIA DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 209. NIGERIA DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 210. NIGERIA DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 211. NIGERIA DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 212. NIGERIA DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 213. NORWAY DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 214. NORWAY DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 215. NORWAY DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 216. NORWAY DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 217. NORWAY DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 218. NORWAY DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 219. POLAND DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 220. POLAND DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 221. POLAND DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 222. POLAND DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 223. POLAND DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 224. POLAND DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 225. QATAR DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 226. QATAR DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 227. QATAR DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 228. QATAR DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 229. QATAR DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 230. QATAR DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 231. RUSSIA DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 232. RUSSIA DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 233. RUSSIA DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 234. RUSSIA DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 235. RUSSIA DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 236. RUSSIA DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 238. SAUDI ARABIA DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 239. SAUDI ARABIA DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 240. SAUDI ARABIA DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 241. SAUDI ARABIA DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 242. SAUDI ARABIA DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 243. SOUTH AFRICA DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 244. SOUTH AFRICA DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 245. SOUTH AFRICA DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 246. SOUTH AFRICA DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 247. SOUTH AFRICA DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 248. SOUTH AFRICA DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 249. SPAIN DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 250. SPAIN DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 251. SPAIN DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 252. SPAIN DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 253. SPAIN DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 254. SPAIN DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 255. SWEDEN DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 256. SWEDEN DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 257. SWEDEN DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 258. SWEDEN DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 259. SWEDEN DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 260. SWEDEN DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 261. SWITZERLAND DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 262. SWITZERLAND DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 263. SWITZERLAND DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 264. SWITZERLAND DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 265. SWITZERLAND DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 266. SWITZERLAND DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 267. TURKEY DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 268. TURKEY DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 269. TURKEY DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 270. TURKEY DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 271. TURKEY DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 272. TURKEY DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED ARAB EMIRATES DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED ARAB EMIRATES DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED ARAB EMIRATES DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED ARAB EMIRATES DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED ARAB EMIRATES DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED ARAB EMIRATES DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM DRUG TESTING MARKET SIZE, BY DRUG TESTING PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 280. UNITED KINGDOM DRUG TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 281. UNITED KINGDOM DRUG TESTING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 282. UNITED KINGDOM DRUG TESTING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 283. UNITED KINGDOM DRUG TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 284. UNITED KINGDOM DRUG TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 285. DRUG TESTING MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 286. DRUG TESTING MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 287. DRUG TESTING MARKET LICENSE & PRICING